Biliary tract cancer incidence in the United States - Demographic and temporal variations by anatomic site

International Journal of Cancer

Volumn 133, Issue 7, 2013, Pages 1664-1671

  Castro, Felipe A ^a   Koshiol, Jill ^a   Hsing, Ann W ^a,b,c   Devesa, Susan S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

Author keywords

ampulla of Vater cancer; biliary tract cancer; extrahepatic bile duct cancer; gallbladder cancer; incidence; Klatskin tumors

Indexed keywords

ADULT; AGE; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; BILIARY TRACT CANCER; CANCER INCIDENCE; CAUCASIAN; DEMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; GALLBLADDER CANCER; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PACIFIC ISLANDER; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; TUMOR LOCALIZATION; UNITED STATES; VATER PAPILLA CARCINOMA;

AMPULLA OF VATER CANCER; BILIARY TRACT CANCER; EXTRAHEPATIC BILE DUCT CANCER; GALLBLADDER CANCER; INCIDENCE; KLATSKIN TUMORS;

AMPULLA OF VATER; BILE DUCT NEOPLASMS; BILIARY TRACT NEOPLASMS; COMMON BILE DUCT NEOPLASMS; CONTINENTAL POPULATION GROUPS; DEMOGRAPHY; ETHNIC GROUPS; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; INCIDENCE; MALE; SEER PROGRAM; UNITED STATES;

EID: 84880254377     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28161     Document Type: Article

References (50)

1. Howlader N, Noone NA, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, Available at: http://seer.cancer.gov/csr/1975-2009-pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012, 2012.
2. Hsing A, Rashid A, Devesa S, et al. Biliary tract cancer. In:, Schottenfeld D, Fraumeni JF, Jr, eds. Cancer epidemiology and prevention, 3rd edn. New York: Oxford University Press, Inc., 2006. 787-800.
3. Randi G, Franceschi S, La Vecchia C,. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-602.
4. Goodman MT, Yamamoto J,. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002. Cancer Causes Control 2007; 18: 415-22.
5. Le MD, Henson D, Young H, et al. Is gallbladder cancer decreasing in view of increasing laparoscopic cholecystectomy? Ann Hepatol 2011; 10: 306-14.
6. Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology, 3rd edn. Geneva: World Health Organization, 2000.
7. Surveillance E, and End Results (SEER) Program. SEER Programme (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 13 Regs Research Data, Nov 2011 Sub (1992-2009), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2012 (updated 05/24/2012), based on the November 2011 submission. 2012.
8. Surveillance E, and End Results (SEER) Program. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Research Data, Nov 2011 Sub (1973-2009), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2012 (updated 05/24/2012), based on the November 2011 submission, 2012.
9. Lemrow SM, Perdue DG, Stewart SL, et al. Gallbladder cancer incidence among American Indians and Alaska Natives, US, 1999-2004. Cancer 2008; 113: 1266-73.
10. Welzel TM, McGlynn KA, Hsing AW, et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006; 98: 873-5.
11. Klatskin G,. Adenocarcinoma of the hepatic duct at its bifurcation within the Porta Hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241-56.
12. Tiwari RC, Clegg LX, Zou Z,. Efficient interval estimation for age-adjusted cancer rates. Statist Meth Med Res 2006; 15: 547-69.
13. Devesa SS, Donaldson J, Fears T,. Graphical presentation of trends in rates. Am J Epidemiol 1995; 141: 300-4.
14. Albores-Saavedra J, Batich K, Hossain S, et al. Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. Ann Diagn Pathol 2009; 13: 378-83.
15. Albores-Saavedra J, Schwartz AM, Batich K, et al. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 2009; 100: 598-605.
16. Chow WH, McLaughlin JK, Menck HR, et al. Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Causes Control 1994; 5: 267-72.
17. Fraumeni JF, Jr,. Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res 1975; 35: 3437-46.
18. Strom BL, Hibberd PL, Soper KA, et al. International variations in epidemiology of cancers of the extrahepatic biliary tract. Cancer Res 1985; 45: 5165-8.
19. Koea J, Phillips A, Lawes C, et al. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: demographics, pathology and survival. ANZ J Surg 2002; 72: 857-61.
20. Randi G, Malvezzi M, Levi F, et al. Epidemiology of biliary tract cancers: an update. Ann Oncol 2009; 20: 146-59.
21. Hsing AW, Gao YT, Han TQ, et al. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 2007; 97: 1577-82.
22. Cuevas A, Molina A, Rigotti A, et al. Trends in obesity and diabetes prevalence in a Chilean urban population: 1993-2001. Metab Syndr Relat Disord 2008; 6: 219-22.
23. Haffner SM, Diehl AK, Stern MP, et al. Central adiposity and gallbladder disease in Mexican Americans. Am J Epidemiol 1989; 129: 587-95.
24. Stinton LM, Shaffer EA,. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 2012; 6: 172-87.
25. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200.
26. Henson DE, Schwartz AM, Nsouli H, et al. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study. Arch Pathol Lab Med 2009; 133: 67-71.
27. McKernan JB,. Origin of laparoscopic cholecystectomy in the USA: personal experience. World J Surg 1999; 23: 332-3.
28. Health, United States, 2011: with special feature on socioeconomic status and healthed. Hyattsville (MD), 2012.
29. Witjes CD, van den Akker SA, Visser O, et al. Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989. Dig Surg 2012; 29: 92-8.
30. Diehl AK, Beral V,. Cholecystectomy and changing mortality from gallbladder cancer. Lancet 1981; 2: 187-9.
31. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001; 51: 349-64.
32. Levi F, Lucchini F, Negri E, et al. The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev 2003; 12: 265-7.
33. Wood R, Fraser LA, Brewster DH, et al. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998. Eur J Cancer 2003; 39: 2080-6.
34. Ford ES, Giles WH, Mokdad AH,. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444-9.
35. Hsing AW, Gao YT, Devesa SS, et al. Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer 1998; 75: 368-70.
36. Shin HR, Oh JK, Masuyer E, et al. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma-focus on East and South-Eastern Asia. Asian Pac J Cancer Prev 2010; 11: 1159-66.
37. Lepage C, Cottet V, Chauvenet M, et al. Trends in the incidence and management of biliary tract cancer: a French population-based study. J Hepatol 2011; 54: 306-10.
38. Khan SA, Emadossadaty S, Ladep NG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 2012; 56: 848-54.
39. Nordenstedt H, Mattsson F, El-Serag H, et al. Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma. Br J Cancer 2012; 106: 1011-5.
40. Shebl FM, Andreotti G, Meyer TE, et al. Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China. Br J Cancer 2011; 105: 1424-9.
41. Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 2007; 5: 1221-8.
42. (WHO) WHO. Manual of International Statistical Classification of Diseases, Injuries and Causes of Deathed. Geneva, Switzerland, 1957.
43. (WHO) WHO. Manual of International Statistical Classification of Diseases, Injuries and Causes of Deathed. Geneva, Switzerland, 1967.
44. (WHO) WHO. Manual of International Statistical Classification of Diseases, Injuries and Causes of Deathed. Geneva, Switzerland, 1977.
45. (WHO) WHO. Manual of International Statistical Classification of Diseases, Injuries and Causes of Deathed. Geneva, Switzerland, 1992.
46. Percy CL, Berg JW, Thomas LB., Manual of tumor nomenclature and coding. New York: American Cancer Society, 1968.
47. World Health Organization. International Classification of Diseases for Oncology, 1st edn. Geneva, Switzerland: World Health Organization, 1976.
48. Percy C, Van Holten V, Muir C,. International classification of diseases for oncology, 2nd edn. Geneva, Switzerland: World Health Organization, 1990.
49. Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology, 3rd edn. Geneva, Switzerland: World Health Organization, 2000.
50. Saika K, Matsuda T,. Comparison of time trends in gallbladder cancer incidence (1973-1997) in East Asia, Europe and the USA, from cancer incidence in five continents vols IV-VIII. Jpn J Clin Oncol 2007; 37: 974-6.